Concern has been expressed in the celiac disease community that the FDA’s temporary food labeling requirements during COVID-19 apply to gluten. The FDA confirmed that the introduction of unlabeled gluten is not allowed in regulated food products.
Continue ReadingWe are pleased to announce our newest online resource for patients and caregivers to drive policy change to improve the health of those living with celiac disease and accelerate research: iAdvocate.
Continue ReadingOn Friday, I joined three of the leading celiac disease researchers in the world to present to the NIH’s Autoimmune Disease Coordinating Committee (ADCC) the findings from the CDF-sponsored First SSCD Consensus Workshop: Research Opportunities in Celiac Disease 2020.
Continue ReadingThe Voluntary Recommendations for Managing Celiac Disease in Learning Environments provides definitive guidance for schools, parents and caregivers for 504 accommodations for children with celiac disease. Download the guide and watch the video.
Continue ReadingEven in the midst of the COVID-19 pandemic, celiac disease patients need treatments and a cure. On March 8, the Celiac Disease Foundation sponsored the First SSCD Consensus Workshop: Research Opportunities in Celiac Disease 2020 to inform NIH funding needs.
Continue Reading